Pasadena, TX—Kaneka Probiotics has achieved U.S. FDA GRAS Certification for its Cardio Probiotic product, made up of Lactobacillus plantarum KABP-011, L. plantarum KABP-012, and L. plantarum KABP-013.
The strains were initially isolated via a screening process designed to identify strains that have a beneficial effect on lipid metabolism, according to a press release. The resulting formula has been clinically shown to support healthy cholesterol levels already in a normal range.
Mike Kolifrath, Vice President, Sales and Marketing of the Probiotics Division at Kaneka, commented in the press release: “The FDA GRAS certification demonstrates our commitment to a higher level of safety and quality for this ingredient. Brands can be assured to have best in class ingredient when selecting to use the Cardio Probiotic raw material blend in their products for lipid metabolism and cardiovascular benefits.”